People: Quest Diagnostics Inc (DGX.N)

DGX.N on New York Stock Exchange

1:40am IST
Change (% chg)

$-0.38 (-0.37%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Doherty, Catherine 

Ms. Catherine T. Doherty is a Senior Vice President, Group Executive - Clinical Franchise Solutions and Marketing of the Company. Since January 2013, Ms. Doherty has been responsible for overseeing the development of clinical franchise solutions in the areas of cardiovascular, infectious disease and immunology, and prescription drug monitoring and toxicology, as well as enterprise-wide strategic marketing. From January 2013 to January 2017, she also was responsible for clinical franchise solutions in the areas of neurology, women's health and general wellness. In February 2014, Ms. Doherty assumed responsibility for the employer solutions and risk assessment businesses. From February 2014 to January 2017, she also was responsible for the healthcare information technology business. From May 2011 to December 2012, she served as Senior Vice President, Physician Services. Prior to May 2011, Ms. Doherty held a variety of positions of increasing responsibility since joining the Company in 1990, including Vice President, Hospital Services; Vice President, Office of the Chairman; Vice President, Finance and Administration for the Hospital business; Vice President, Communications and Investor Relations; and Chief Accounting Officer.

Basic Compensation

Total Annual Compensation, USD 994,175
Restricted Stock Award, USD 900,090
Long-Term Incentive Plans, USD --
All Other, USD 637,751
Fiscal Year Total, USD 2,532,020

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 139,762 5,921,890.00
Name Fiscal Year Total

Stephen Rusckowski


Mark Guinan


James Davis


Gabrielle Wolfson


Michael Prevoznik


Jon Cohen

As Of  31 Dec 2017